NRSN
NRSN is Already Collaborating with World Renowned Names Like Mass General Hospital & Harvard Medical School NRSN Looks to be in the Midst of Exploding Off of Recent Lows After Finding Support CHECK OUT THE INVESTOR PRESENTATION HERE __________________________ Hello Everyone, I hope that you have been watching our last few profiles. Several of our more […]
ENLV
Allocetra™ is being developed as an adjunctive therapy for preventing organ failure and mortality in sepsis, in combination with existing antibiotics agents Favorable safety profile demonstrated across 140+ patients Management team with a track record of creating shareholder value and getting drug products through marketing approvals globally in multi-billion dollar market segments First patient dosed […]
KULR Profile
Revenue increased 146% to $9,830,166 in 2023 from $3,994,634 in 2022 KULR ENTERS INTO AN AGREEMENT WITH LOCKHEED MARTIN FOR HEAT SINK ADVANCEMENTS IN PRECISION MISSILE ELECTRONICS KULR Secured a pivotal contract exceeding from Nanoracks who is now part of Voyager Space’s Exploration Segment KULR Technology Group Lends Battery Production Infrastructure for Rapid Support of […]
ATAI
Cash, cash equivalents and short-term investments totaled $121.3 million as of March 31, 2024 ATAI offers a diverse pipeline of drugs and a focus on compounds with prior evidence in humans, upcoming inflection points (multiple Phase 1 and Phase 2 proof-of-concept trial readouts are expected in the next two years) With prominent backing from venture […]
GWAV
Greenwave Technology Solutions Generates More than $9 Million Revenue in Q4 2023 GWAV Achieved over $30M in revenues last year and is on track to generate record revenues this year GWAV operates 13 metal recycling facilities in Virginia, North Carolina, and Cleveland, OH Company has improved its balance sheet by $27 million over the past […]
EFSH Profile
1847 Reports 15.0% Increase in Revenue to $14.9 Million for the First Quarter of 2024 1847 Executes Letter of Intent to Sell 1847 Cabinets Inc. for $27.6 Million Check Out the Investor Presentation HERE __________________________________________________ Hello Everyone, We have another profile that we need to get on your radar heading into this week. Pull […]
UMAC
Read the Investor Presentation HERE Just 2 weeks ago, CEO Allan Evans, COO Drew Camden, and 2 board members collectively acquired more than 40,000 shares through open market purchases For the 45 days post-acquisition in the first quarter, UMAC generated approximately $619,000 in combined sales UMAC is focused on becoming a leading supplier to the American drone […]
NNVC
As of December 31, 2023 NNVC had cash and cash equivalent current assets balance of approximately $5.31 Million This Innovative Biotech Company Is Taking A Novel, Game-Changing Approach To Eradicating Many Respiratory Viruses Once And For All Including Tripledemic Threat Of COVID, RSV, FLU… ANTIBODIES AND VACCINES ARE OUTDATED: NanoViricides, Inc has a more innovative approach […]
GVH
Globavend Holdings Announces MOU to Acquire Top Logistics, a Key One-stop Logistics Solutions Provider in Australia Specializing in Direct Injection from Hong Kong & Southern China to Australia and New Zealand The company’s revenues nearly doubled from FY2021 to 2022 — from USD $13.3M to $24M — before dropping a bit to $18.6M in 2023 GVH’s […]
(NYSE: MAIA) Profile
______________________ MAIA BOASTS A ROBUST CLINICAL PIPELINE IN MULTIPLE HARD-TO-TREAT CANCER INDICATIONS FDA GRANTS ORPHAN DRUG DESIGNATION TO MAIA BIOTECHNOLOGY FOR THIO AS A TREATMENT FOR GLIOBLASTOMA. -THIS IS THE THIRD ORPHAN DRUG DESIGNATION GRANTED TO THIO MAIA Just Made Another 52 Week High Earlier in This Session READ THE INVESTOR PRESENTATION HERE _______________________________________________________________________________________________________________ […]